AKBA
Akebia Therapeutics Inc
Price:  
1.58 
USD
Volume:  
1,964,803.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Relative Valuation

-534.4%
Upside

As of 2024-03-01, the Relative Valuation of Akebia Therapeutics Inc (AKBA) is (6.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.58 USD, the upside of Akebia Therapeutics Inc based on Relative Valuation is -534.4%.

The range of the Relative Valuation is (6.38) - (6.50) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 19.4x - 28.1x 24.3x
Forward P/E multiples 15.5x - 19.8x 17.6x
Fair Price (6.38) - (6.50) (6.86)
Upside -503.6% - -511.1% -534.4%
1.58 USD
Stock Price
(6.86) USD
Fair Price

AKBA Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -5.14
2024-02-29 -4.82
2024-02-28 -4.69
2024-02-27 -5.00
2024-02-26 -4.60
2024-02-23 -4.12
2024-02-22 -4.24
2024-02-21 -4.33
2024-02-20 -4.39
2024-02-16 -4.42
2024-02-15 -4.48
2024-02-14 -4.66
2024-02-13 -4.63
2024-02-12 -4.94
2024-02-09 -5.00
2024-02-08 -4.97
2024-02-07 -5.03
2024-02-06 -5.12
2024-02-05 -5.03
2024-02-02 -5.03
2024-02-01 -5.21
2024-01-31 -5.12
2024-01-30 -5.00
2024-01-29 -5.46
2024-01-26 -4.94
2024-01-25 -4.57
2024-01-24 -4.48
2024-01-23 -4.27
2024-01-22 -4.24
2024-01-19 -4.27
2024-01-18 -4.27
2024-01-17 -4.33
2024-01-16 -4.42
2024-01-12 -4.72
2024-01-11 -4.72
2024-01-10 -4.82
2024-01-09 -4.76
2024-01-08 -4.79
2024-01-05 -4.51
2024-01-04 -4.63
2024-01-03 -4.18
2024-01-02 -3.87
2023-12-29 -3.78
2023-12-28 -3.90
2023-12-27 -3.66
2023-12-26 -3.63
2023-12-22 -3.63
2023-12-21 -3.66
2023-12-20 -3.66
2023-12-19 -3.63